secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001274737-23-000046
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen Q1: record 37,312 AVISE CTD tests, revenue $11.2M (+8% YoY), net loss narrows to $7.7M
--------------------------------------------------------------------------------

- Delivered 37,312 AVISE CTD tests (+21% YoY); Q2 2023 revenue guided $10.7-11.2M.
- Total revenue $11.2M (+8% YoY); gross margin improved to 47.2% from 44.0%.
- Operating expenses $18.9M (-5.7% YoY); net loss $7.7M vs. $10.3M loss in Q1 2022.
- AVISE CTD trailing 12-month ASP $279; cash and equivalents $52.2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473723000046/0001274737-23-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473723000046/exdx-20230515.htm
  HTML page:      https://secwatch.observer/filing/0001274737-23-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer